Keyphrases
Helicobacter Pylori (H. pylori)
100%
Urea Breath Test
45%
Inflammatory Bowel Disease
43%
Crohn's Disease
39%
Thioacetamide
34%
Helicobacter Pylori Infection
30%
Liver Damage
28%
Concanavalin A (Con A)
25%
Proton Pump Inhibitors
25%
P27Kip1
25%
Tumor Necrosis Factor-α
21%
Achalasia
21%
Colonoscopy
21%
Israeli
19%
Breath Test
19%
Hepatic Damage
18%
Israel
18%
Apoptosis
18%
Iron Deficiency Anemia
18%
Liver Cirrhosis
17%
High-resolution Manometry
17%
Glucagon-like peptide-1 Receptor (GLP-1R)
17%
Concanavalin A-induced Hepatitis
16%
Glucagon-like
16%
Colon Cancer Cells
13%
A1 Receptor
13%
Liver Injury
12%
High-resolution Esophageal Manometry
12%
Hypothyroidism
12%
Maintenance Therapy
12%
Receptor Expression
12%
Helicobacter Pylori Eradication
12%
Esophagogastroduodenoscopy
12%
Clinical Presentation
11%
Liver
11%
Gastric Cancer
11%
Serum Levels
11%
Endoscopy
10%
Fulminant Hepatic Failure
10%
Celiac Disease
10%
Dimethyl Sulfoxide
10%
Arg-Gly-Asp
10%
Liver Enzymes
10%
Gastroenterologist
10%
Etiology
10%
Gastric Epithelial Cells
10%
Diabetic Patients
9%
Immune Response
9%
Dimethylthiourea
9%
Integrated Relaxation Pressure
9%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Injury
54%
Helicobacter Pylori
45%
Mouse
40%
Urea Breath Test
37%
Urea C 13
34%
Thioacetamide
33%
Crohn's Disease
24%
Tumor Necrosis Factor
24%
Concanavalin A
21%
Proton Pump Inhibitor
20%
Liver Cirrhosis
19%
Infection
18%
Stomach Cancer
17%
Inflammatory Bowel Disease
17%
Concanavalin A-Induced Hepatitis
16%
Disease
16%
Scavenger
13%
Prevalence
12%
Hypothyroidism
12%
Ulcerative Colitis
12%
Colon Cancer
12%
Liver Enzyme
11%
Helicobacter Infection
10%
Fulminant Hepatic Failure
10%
Dimethyl Sulfoxide
10%
Arginylglycylaspartic Acid
10%
Placebo
10%
Malignant Neoplasm
9%
Dimethylthiourea
9%
Receptor
9%
Cyclin Dependent Kinase Inhibitor
9%
Neoplasm
9%
Diabetes Mellitus
9%
Inflammation
9%
Symptom
9%
Carbon 13
8%
Adhesive Agent
8%
Experimental Liver Injury
8%
Adverse Event
8%
Carcinogenesis
8%
Liver Disease
8%
Hydroxyl Radical
8%
Etrolizumab
8%
Colorectal Cancer
8%
Octanoic Acid
8%
Glucagon Like Peptide 1 Receptor Agonist
8%
Fatty Liver
7%
Aminotransferase
7%
Non-Steroidal Anti-Inflammatory Drug
7%
Integrin Receptor
6%
Medicine and Dentistry
Helicobacter Pylori
72%
Pylorus
51%
Urea Breath Test
27%
Prevalence
25%
Urea C 13
24%
Symptom
22%
Endoscopy
22%
Breathing
22%
High Resolution Manometry
21%
Disease
21%
Colonoscopy
21%
Achalasia
21%
Inflammatory Bowel Disease
19%
Crohn's Disease
18%
Hypochromic Anemia
17%
Proton-Pump Inhibitor
16%
Infection
16%
Gastritis
13%
Receptor Expression
12%
Drug Therapy
12%
Esophagogastroduodenoscopy
12%
Diabetes Mellitus
11%
Ulcerative Colitis
11%
Coeliac Disease
11%
Helicobacter Infection
10%
Esophagus
10%
Muscle Contractility
9%
Glucagon Like Peptide 1 Receptor
9%
Randomized Controlled Trial
8%
Diabetes
8%
Adenoma
8%
Biological Therapy
8%
Adolescent
8%
Hepatitis C
8%
Lymphatic Follicle
8%
Primary Health Care
8%
Maintenance Therapy
8%
Etrolizumab
8%
Satiety
8%
Glucagon-Like Peptide-1 Agonist
8%
Carbon 13
7%
Health Care Cost
7%
Diagnosis
7%
Gastroesophageal Reflux
6%
Nonsteroid Antiinflammatory Agent
6%
Neoplasm
6%
Cyclin Dependent Kinase Inhibitor
6%
Pediatrics
6%
Population
6%
Placebo
6%